{"id":"https://openalex.org/W1908826089","doi":"https://doi.org/10.1111/bcp.12277","title":"Misuse of the \u03b3\u2010aminobutyric acid analogues baclofen, gabapentin and pregabalin in the UK","display_name":"Misuse of the \u03b3\u2010aminobutyric acid analogues baclofen, gabapentin and pregabalin in the UK","publication_year":2013,"publication_date":"2013-11-06","ids":{"openalex":"https://openalex.org/W1908826089","doi":"https://doi.org/10.1111/bcp.12277","mag":"1908826089","pmid":"https://pubmed.ncbi.nlm.nih.gov/25083536"},"language":"en","primary_location":{"id":"doi:10.1111/bcp.12277","doi":"https://doi.org/10.1111/bcp.12277","is_oa":false,"landing_page_url":"https://doi.org/10.1111/bcp.12277","pdf_url":null,"source":{"id":"https://openalex.org/S13842274","display_name":"British Journal of Clinical Pharmacology","issn_l":"0306-5251","issn":["0306-5251","1365-2125"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Clinical Pharmacology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4168395","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5017272739","display_name":"Vikas Kapil","orcid":"https://orcid.org/0000-0001-5778-6188","observed_orcids":["https://orcid.org/0000-0001-5778-6188"]},"institutions":[{"id":"https://openalex.org/I166337079","display_name":"Queen Mary University of London","ror":"https://ror.org/026zzn846","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079"]},{"id":"https://openalex.org/I200166805","display_name":"Guy's and St Thomas' NHS Foundation Trust","ror":"https://ror.org/00j161312","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I200166805"]},{"id":"https://openalex.org/I225661044","display_name":"Barts Health NHS Trust","ror":"https://ror.org/00b31g692","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I225661044"]},{"id":"https://openalex.org/I4210113441","display_name":"Kings Health Partners","ror":"https://ror.org/01xcsye48","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210113441"]},{"id":"https://openalex.org/I4210149920","display_name":"William Harvey Research Institute","ror":"https://ror.org/0574dzy90","country_code":"GB","type":"facility","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079","https://openalex.org/I4210149920"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Vikas Kapil","raw_affiliation_strings":["Barts Health NHS Trust  London UK","Clinical Toxicology Guy's and St Thomas' NHS Foundation Trust and King's Health Partners  London UK","William Harvey Research Institute Centre for Clinical Pharmacology Barts and the London School of Medicine and Dentistry Queen Mary University of London  London UK","Barts Health NHS Trust; London UK","Clinical Toxicology Guy's and St Thomas' NHS Foundation Trust and King's Health Partners London UK","William Harvey Research Institute, Centre for Clinical Pharmacology, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Barts Health NHS Trust  London UK","institution_ids":["https://openalex.org/I225661044"]},{"raw_affiliation_string":"Clinical Toxicology Guy's and St Thomas' NHS Foundation Trust and King's Health Partners  London UK","institution_ids":["https://openalex.org/I200166805","https://openalex.org/I4210113441"]},{"raw_affiliation_string":"William Harvey Research Institute Centre for Clinical Pharmacology Barts and the London School of Medicine and Dentistry Queen Mary University of London  London UK","institution_ids":["https://openalex.org/I166337079","https://openalex.org/I4210149920"]},{"raw_affiliation_string":"Barts Health NHS Trust; London UK","institution_ids":["https://openalex.org/I225661044"]},{"raw_affiliation_string":"Clinical Toxicology Guy's and St Thomas' NHS Foundation Trust and King's Health Partners London UK","institution_ids":["https://openalex.org/I200166805","https://openalex.org/I4210113441"]},{"raw_affiliation_string":"William Harvey Research Institute, Centre for Clinical Pharmacology, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK","institution_ids":["https://openalex.org/I166337079","https://openalex.org/I4210149920"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049983183","display_name":"Jody L. Green","orcid":"https://orcid.org/0000-0003-1776-6400","observed_orcids":["https://orcid.org/0000-0003-1776-6400"]},"institutions":[{"id":"https://openalex.org/I2801983979","display_name":"Denver Health Medical Center","ror":"https://ror.org/01fbz6h17","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2801983979"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jody L. Green","raw_affiliation_strings":["Denver Health Rocky Mountain Poison and Drug Center  Denver CO USA","Denver Health Rocky Mountain Poison and Drug Center Denver CO USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Denver Health Rocky Mountain Poison and Drug Center  Denver CO USA","institution_ids":["https://openalex.org/I2801983979"]},{"raw_affiliation_string":"Denver Health Rocky Mountain Poison and Drug Center Denver CO USA","institution_ids":["https://openalex.org/I2801983979"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027524322","display_name":"Marie\u2010Claire Le Lait","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801983979","display_name":"Denver Health Medical Center","ror":"https://ror.org/01fbz6h17","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2801983979"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Marie\u2010Claire Le Lait","raw_affiliation_strings":["Denver Health Rocky Mountain Poison and Drug Center  Denver CO USA","Denver Health Rocky Mountain Poison and Drug Center Denver CO USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Denver Health Rocky Mountain Poison and Drug Center  Denver CO USA","institution_ids":["https://openalex.org/I2801983979"]},{"raw_affiliation_string":"Denver Health Rocky Mountain Poison and Drug Center Denver CO USA","institution_ids":["https://openalex.org/I2801983979"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015960673","display_name":"David Michael Wood","orcid":"https://orcid.org/0000-0002-7826-7237","observed_orcids":["https://orcid.org/0000-0002-7826-7237"]},"institutions":[{"id":"https://openalex.org/I183935753","display_name":"King's College London","ror":"https://ror.org/0220mzb33","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I183935753"]},{"id":"https://openalex.org/I200166805","display_name":"Guy's and St Thomas' NHS Foundation Trust","ror":"https://ror.org/00j161312","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I200166805"]},{"id":"https://openalex.org/I4210113441","display_name":"Kings Health Partners","ror":"https://ror.org/01xcsye48","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210113441"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"David M. Wood","raw_affiliation_strings":["Clinical Toxicology Guy's and St Thomas' NHS Foundation Trust and King's Health Partners  London UK","King's College London  London UK","Clinical Toxicology, Guy's and St Thomas' NHS Foundation Trust and King's Health Partners, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Toxicology Guy's and St Thomas' NHS Foundation Trust and King's Health Partners  London UK","institution_ids":["https://openalex.org/I200166805","https://openalex.org/I4210113441"]},{"raw_affiliation_string":"King's College London  London UK","institution_ids":["https://openalex.org/I183935753"]},{"raw_affiliation_string":"Clinical Toxicology, Guy's and St Thomas' NHS Foundation Trust and King's Health Partners, London, UK","institution_ids":["https://openalex.org/I200166805","https://openalex.org/I4210113441"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5019447625","display_name":"Paul Ivor Dargan","orcid":"https://orcid.org/0000-0002-3433-9622","observed_orcids":["https://orcid.org/0000-0002-3433-9622"]},"institutions":[{"id":"https://openalex.org/I183935753","display_name":"King's College London","ror":"https://ror.org/0220mzb33","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I183935753"]},{"id":"https://openalex.org/I200166805","display_name":"Guy's and St Thomas' NHS Foundation Trust","ror":"https://ror.org/00j161312","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I200166805"]},{"id":"https://openalex.org/I4210113441","display_name":"Kings Health Partners","ror":"https://ror.org/01xcsye48","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210113441"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Paul I. Dargan","raw_affiliation_strings":["Clinical Toxicology Guy's and St Thomas' NHS Foundation Trust and King's Health Partners  London UK","King's College London  London UK","Clinical Toxicology, Guy's and St Thomas' NHS Foundation Trust and King's Health Partners, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Toxicology Guy's and St Thomas' NHS Foundation Trust and King's Health Partners  London UK","institution_ids":["https://openalex.org/I200166805","https://openalex.org/I4210113441"]},{"raw_affiliation_string":"King's College London  London UK","institution_ids":["https://openalex.org/I183935753"]},{"raw_affiliation_string":"Clinical Toxicology, Guy's and St Thomas' NHS Foundation Trust and King's Health Partners, London, UK","institution_ids":["https://openalex.org/I200166805","https://openalex.org/I4210113441"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":7,"corresponding_author_ids":["https://openalex.org/A5017272739"],"corresponding_institution_ids":["https://openalex.org/I166337079","https://openalex.org/I200166805","https://openalex.org/I225661044","https://openalex.org/I4210113441","https://openalex.org/I4210149920"],"apc_list":{"value":4780,"currency":"USD","value_usd":4780},"apc_paid":null,"fwci":5.063,"has_fulltext":false,"cited_by_count":98,"citation_normalized_percentile":{"value":0.95014598,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":94,"max":100},"biblio":{"volume":"78","issue":"1","first_page":"190","last_page":"191"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10576","display_name":"Opioid Use Disorder Treatment","score":0.9110999703407288,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10576","display_name":"Opioid Use Disorder Treatment","score":0.9110999703407288,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10043","display_name":"Substance Abuse Treatment and Outcomes","score":0.058400001376867294,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10800","display_name":"Forensic Toxicology and Drug Analysis","score":0.016200000420212746,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/drug-abuse","display_name":"drug abuse","score":0.7919999957084656},{"id":"https://openalex.org/keywords/gaba-analogues","display_name":"GABA analogues","score":0.8849999904632568},{"id":"https://openalex.org/keywords/baclofen","display_name":"baclofen","score":0.996999979019165},{"id":"https://openalex.org/keywords/gabapentin","display_name":"gabapentin","score":1.0},{"id":"https://openalex.org/keywords/pregabalin","display_name":"pregabalin","score":1.0},{"id":"https://openalex.org/keywords/recreational-drug-use","display_name":"recreational drug use","score":0.6439999938011169},{"id":"https://openalex.org/keywords/online-pharmacies","display_name":"online pharmacies","score":0.4169999957084656},{"id":"https://openalex.org/keywords/prescription-drug-misuse","display_name":"prescription drug misuse","score":0.5600000023841858},{"id":"https://openalex.org/keywords/drug-addiction","display_name":"drug addiction","score":0.33899998664855957},{"id":"https://openalex.org/keywords/withdrawal-symptoms","display_name":"withdrawal symptoms","score":0.3840000033378601},{"id":"https://openalex.org/keywords/internet-based-survey","display_name":"internet-based survey","score":0.6050000190734863},{"id":"https://openalex.org/keywords/consumer-panel","display_name":"consumer panel","score":0.47999998927116394},{"id":"https://openalex.org/keywords/lifetime-prevalence","display_name":"lifetime prevalence","score":0.43299999833106995},{"id":"https://openalex.org/keywords/pharmacovigilance","display_name":"pharmacovigilance","score":0.7110000252723694},{"id":"https://openalex.org/keywords/anxiety-disorders","display_name":"anxiety disorders","score":0.3889999985694885},{"id":"https://openalex.org/keywords/neuropathic-pain-management","display_name":"neuropathic pain treatment","score":0.8230000138282776},{"id":"https://openalex.org/keywords/cannabis","display_name":"cannabis","score":0.9919999837875366}],"concepts":[{"id":"https://openalex.org/C2776468701","wikidata":"https://www.wikidata.org/wiki/Q412174","display_name":"Pregabalin","level":2,"score":0.9773510098457336},{"id":"https://openalex.org/C2776608144","wikidata":"https://www.wikidata.org/wiki/Q410352","display_name":"Gabapentin","level":3,"score":0.8725935220718384},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7364176511764526},{"id":"https://openalex.org/C2777683783","wikidata":"https://www.wikidata.org/wiki/Q221174","display_name":"Topiramate","level":3,"score":0.5551356673240662},{"id":"https://openalex.org/C2780837902","wikidata":"https://www.wikidata.org/wiki/Q421663","display_name":"Vigabatrin","level":4,"score":0.5470401644706726},{"id":"https://openalex.org/C2426938","wikidata":"https://www.wikidata.org/wiki/Q3355478","display_name":"Medical prescription","level":2,"score":0.5249833464622498},{"id":"https://openalex.org/C57658597","wikidata":"https://www.wikidata.org/wiki/Q1550789","display_name":"Pharmacovigilance","level":3,"score":0.4944639205932617},{"id":"https://openalex.org/C2781201050","wikidata":"https://www.wikidata.org/wiki/Q413717","display_name":"Baclofen","level":4,"score":0.48451489210128784},{"id":"https://openalex.org/C2777107010","wikidata":"https://www.wikidata.org/wiki/Q2798704","display_name":"Neuropathic pain","level":2,"score":0.44916659593582153},{"id":"https://openalex.org/C48856860","wikidata":"https://www.wikidata.org/wiki/Q12029","display_name":"Addiction","level":2,"score":0.42686372995376587},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.4112669825553894},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.36632248759269714},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.31371742486953735},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.24446779489517212},{"id":"https://openalex.org/C2775858608","wikidata":"https://www.wikidata.org/wiki/Q576618","display_name":"Anticonvulsant","level":3,"score":0.20442938804626465},{"id":"https://openalex.org/C2778186239","wikidata":"https://www.wikidata.org/wiki/Q41571","display_name":"Epilepsy","level":2,"score":0.18000978231430054},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.1090516448020935},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.0},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000069583","descriptor_name":"Pregabalin","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000069583","descriptor_name":"Pregabalin","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000069583","descriptor_name":"Pregabalin","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000077206","descriptor_name":"Gabapentin","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000077206","descriptor_name":"Gabapentin","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000077206","descriptor_name":"Gabapentin","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000588","descriptor_name":"Amines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000588","descriptor_name":"Amines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000588","descriptor_name":"Amines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D001418","descriptor_name":"Baclofen","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D001418","descriptor_name":"Baclofen","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D001418","descriptor_name":"Baclofen","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D003509","descriptor_name":"Cyclohexanecarboxylic Acids","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D003509","descriptor_name":"Cyclohexanecarboxylic Acids","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D003509","descriptor_name":"Cyclohexanecarboxylic Acids","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005680","descriptor_name":"gamma-Aminobutyric Acid","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D005680","descriptor_name":"gamma-Aminobutyric Acid","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D005680","descriptor_name":"gamma-Aminobutyric Acid","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D005680","descriptor_name":"gamma-Aminobutyric Acid","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D005680","descriptor_name":"gamma-Aminobutyric Acid","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D005680","descriptor_name":"gamma-Aminobutyric Acid","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D006113","descriptor_name":"United Kingdom","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D006113","descriptor_name":"United Kingdom","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D006113","descriptor_name":"United Kingdom","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D006306","descriptor_name":"Health Surveys","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006306","descriptor_name":"Health Surveys","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006306","descriptor_name":"Health Surveys","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013287","descriptor_name":"Illicit Drugs","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D013287","descriptor_name":"Illicit Drugs","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D013287","descriptor_name":"Illicit Drugs","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D063487","descriptor_name":"Prescription Drug Misuse","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":false},{"descriptor_ui":"D063487","descriptor_name":"Prescription Drug Misuse","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":false},{"descriptor_ui":"D063487","descriptor_name":"Prescription Drug Misuse","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1111/bcp.12277","doi":"https://doi.org/10.1111/bcp.12277","is_oa":false,"landing_page_url":"https://doi.org/10.1111/bcp.12277","pdf_url":null,"source":{"id":"https://openalex.org/S13842274","display_name":"British Journal of Clinical Pharmacology","issn_l":"0306-5251","issn":["0306-5251","1365-2125"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Clinical Pharmacology","raw_type":"journal-article"},{"id":"pmid:25083536","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25083536","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British journal of clinical pharmacology","raw_type":"Letter"},{"id":"pmh:oai:pubmedcentral.nih.gov:4168395","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4168395","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Br J Clin Pharmacol","raw_type":"Text"}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:4168395","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4168395","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Br J Clin Pharmacol","raw_type":"Text"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9940000176429749}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.6100000143051147}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[{"id":"https://openalex.org/G8546579714","display_name":null,"funder_award_id":"CL-2013-19-003","funder_id":"https://openalex.org/F4320319990","funder_display_name":"National Institute for Health and Care Research"}],"funders":[{"id":"https://openalex.org/F4320319990","display_name":"National Institute for Health and Care Research","ror":"https://ror.org/0187kwz08"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":5,"referenced_works":["https://openalex.org/W1977980816","https://openalex.org/W1994385429","https://openalex.org/W2038477728","https://openalex.org/W2148930083","https://openalex.org/W2564033125"],"related_works":["https://openalex.org/W2359317310","https://openalex.org/W2794797808","https://openalex.org/W1720984727","https://openalex.org/W2290108839","https://openalex.org/W3166069603","https://openalex.org/W1837738911","https://openalex.org/W4226315901","https://openalex.org/W2063957311","https://openalex.org/W2003461020","https://openalex.org/W2924513576"],"abstract_inverted_index":{"\u03b3-Aminobutyric":[0],"acid":[1],"(GABA)-analogue":[2],"medications,":[3,566],"including":[4,31,75],"gabapentin":[5,184,298,696],"and":[6,19,33,61,86,112,175,185,249,252,292,299,334,355,385,402,411,418,442,459,466,481,519,543,551,598,697,771,780,790,833],"pregabalin,":[7],"are":[8],"recommended":[9],"first-line":[10],"treatments":[11],"for":[12,59,81,318,353,440,469,479,502,511,517,524,632,739,804,840,889,915],"neuropathic":[13],"pain":[14],"in":[15,24,45,97,131,161,187,240,376,474,535,546,556,657,699,705,855,859],"the":[16,25,51,76,79,92,153,156,172,180,188,220,241,245,265,268,314,349,373,377,436,445,470,475,492,562,600,613,626,629,644,649,670,700,715,721,755,766,775,802,819,830,841,856,860,875,890,900,912,916],"UK":[17,242,378,671],"1,":[18],"pregabalin":[20,698],"has":[21,40,201,736],"been":[22,41,148,622],"used":[23,752],"treatment":[26],"of":[27,47,83,91,94,99,114,122,155,158,166,177,179,207,209,247,259,264,294,296,306,316,327,329,372,425,427,451,453,487,489,491,528,580,618,651,653,664,666,694,707,712,714,720,723,757,777,894],"various":[28],"psychiatric":[29],"conditions,":[30],"generalized":[32],"social":[34],"anxiety":[35],"disorders":[36],"2.":[37],"Consequently,":[38],"there":[39,146,690],"a":[42,193,213,257,276,369,658],"large":[43],"increase":[44],"prescription":[46],"these":[48,84,95,129,159,307,565,746],"drugs":[49,124,331,429,473,668],"over":[50],"last":[52],"decade":[53],"3.":[54],"The":[55,164,261,389,484,526,718,884],"European":[56],"Monitoring":[57],"Centre":[58],"Drugs":[60],"Drug":[62],"Addiction":[63],"(EMCDDA)":[64],"recently":[65],"highlighted":[66],"early":[67,758],"reports":[68],"from":[69,72,88,109,435,574,583,590,599,615,728,829,837],"pharmacovigilance":[70,759],"data":[71,150,263,288,346,434],"four":[73],"countries,":[74],"UK,":[77,701],"regarding":[78,106],"potential":[80],"misuse":[82,113,157,178,295,488,529,652,679,693,711,724,779],"medications":[85,96,130,160,387,496,655],"indications":[87],"toxicological":[89],"analyses":[90],"involvement":[93],"deaths":[98],"users":[100,121],"4.":[101],"There":[102],"is":[103,643,691,792,798,886],"also":[104],"concern":[105],"their":[107,572],"access":[108,127,744],"online":[110,390],"pharmacies":[111],"legitimately":[115,623,732],"prescribed":[116,624,733],"medication":[117,614,619],"5.":[118],"Furthermore,":[119],"dependent":[120],"recreational":[123,330,382,428,472,667],"may":[125],"seek":[126],"to":[128,134,144,170,234,267,272,275,312,381,432,625,640,647,669,726,742,745,753,768,800,806,872,911],"an":[132,202,223,853],"attempt":[133],"prevent":[135],"or":[136,592,683,786,867,892],"treat":[137],"withdrawal":[138],"symptoms":[139],"3,":[140],"6,":[141],"7.":[142,483],"However,":[143],"date":[145],"have":[147,817,852,873],"no":[149,835,844,864],"reported":[151],"on":[152,289,324,788,827],"prevalence":[154,291,326,424,450,486,650,663],"any":[162,490,713,838,848,895],"country.":[163],"aim":[165],"this":[167,359,505],"study":[168],"was":[169,217,392,430,455,497,506,530,628],"determine":[171,754],"prevalence,":[173],"frequency":[174,293,527],"sources":[176,729],"GABA":[181],"analogues":[182],"(baclofen,":[183],"pregabalin)":[186],"UK.":[189],"We":[190,211,320],"partnered":[191],"with":[192,287,379,463,577,606,660,702,847],"global":[194,204],"market":[195,236],"research":[196,237],"company,":[197],"GMI":[198,233],"(http://www.gmi-mr.com/global-panel),":[199],"which":[200,735],"established":[203],"consumer":[205],"panel":[206,238],"millions":[208],"persons.":[210],"devised":[212],"question-based":[214],"survey":[215,225,366,391,446,708],"that":[216,339,364,620,689,763,850,869],"formulated":[218],"by":[219,232,348,394,680,765,899],"company":[221],"into":[222],"Internet-based":[224,880],"(see":[226],"Appendix":[227,878],"S1).":[228],"Invitations":[229],"were":[230,254,270,284,310,413],"sent":[231],"existing":[235,344],"members":[239],"only,":[243],"between":[244,540],"ages":[246],"16":[248],"59":[250],"years,":[251],"respondents":[253,709],"capped":[255],"at":[256,824],"maximum":[258],"1500.":[260],"raw":[262],"responses":[266],"questions":[269,322],"given":[271],"us,":[273],"linked":[274],"fully":[277],"anonymized":[278],"unique":[279],"personal":[280],"identifier.":[281],"Basic":[282],"demographics":[283],"collected":[285],"together":[286],"lifetime":[290,325,449,485,662],"baclofen,":[297,512,695],"pregabalin;":[300],"where":[301],"individuals":[302,396],"had":[303,621],"misused":[304],"one":[305,704],"drugs,":[308],"they":[309],"asked":[311],"indicate":[313],"source(s)":[315],"supply":[317,573,789],"misuse.":[319,388],"included":[321],"based":[323],"use":[328,384,426,452,665,791],"[cocaine,":[332],"cannabis":[333,457],"3,4-methylenedioxy-N-methylamphetamine":[335],"(MDMA,":[336],"'ecstasy')]":[337],"so":[338],"we":[340,361,674],"could":[341,362,870],"benchmark":[342],"against":[343],"national":[345,374,433],"provided":[347,368,764],"2011/2012":[350,437,476],"Crime":[351,438,477],"Survey":[352,439,478],"England":[354,441,480],"Wales":[356,482],"8.":[357],"In":[358,794],"way,":[360],"confirm":[363,677],"our":[365,641,686],"population":[367,375],"reasonable":[370],"sample":[371],"respect":[380],"drug":[383],"therefore":[386],"completed":[393,818],"1500":[395],"[male,":[397],"49.1%":[398],"(n":[399,405,499,508,514,521,537,548,558,568,609,635],"=":[400,406,500,509,515,522,538,549,559,569,588,596,604,610,636],"737)":[401],"female,":[403],"50.9%":[404],"763)];":[407],"9.1,":[408],"40.5,":[409],"21.1":[410],"29.3%":[412],"aged":[414],"16\u201320,":[415],"21\u201339,":[416],"40\u201349":[417],"50\u201359":[419],"years":[420],"old,":[421],"respectively.":[422],"Lifetime":[423],"comparable":[431],"Wales.":[443],"Within":[444],"cohort,":[447],"self-reported":[448],"cocaine":[454],"8.1%,":[456],"28.1%":[458],"MDMA":[460],"8.2%;":[461],"compared":[462],"9.5,":[464],"31.0":[465],"8.6%,":[467],"respectively,":[468],"three":[471,493],"surveyed":[494],"GABA-analogue":[495,654,716],"2.5%":[498],"38);":[501],"each":[503],"drug,":[504],"1.3%":[507],"19)":[510],"1.1%":[513],"17)":[516],"gabapentin,":[518],"0.5%":[520],"8)":[523],"pregabalin.":[525],"less":[531],"than":[532,553,731,905],"once":[533,541,544,554],"monthly":[534,542],"36.8%":[536,567],"14),":[539],"weekly":[545,555],"50%":[547],"19),":[550],"more":[552],"13.1%":[557,634],"5).":[560,637],"Of":[561],"people":[563],"misusing":[564],"14)":[570],"obtained":[571],"multiple":[575],"sources,":[576],"similar":[578,661],"rates":[579],"sourcing":[581],"overall":[582],"health":[584],"services":[585],"(63.1%,":[586],"n":[587,595,603],"24),":[589],"family":[591],"acquaintances":[593],"(57.8%,":[594],"22)":[597],"Internet":[601],"(47.3%,":[602],"18),":[605],"only":[607,633],"7.8%":[608],"3)":[611],"obtaining":[612],"abroad.":[616],"Misuse":[617],"individual":[627],"sole":[630],"source":[631],"This":[638],"study,":[639],"knowledge,":[642],"first":[645],"report":[646],"estimate":[648],"conducted":[656],"cohort":[659],"population.":[672],"Whilst":[673],"did":[675],"not":[676,887],"substance":[678,778],"structured":[681],"interview":[682],"specific":[684],"analysis,":[685],"results":[687],"suggest":[688],"appreciable":[692],"approximately":[703],"40":[706],"self-reporting":[710],"medications.":[717,747],"provenance":[719],"majority":[722],"appears":[725],"be":[727,751,909],"other":[730,865],"medication,":[734],"important":[737],"implications":[738],"future":[740],"strategies":[741],"reduce":[743],"Similar":[748],"surveys":[749],"can":[750],"robustness":[756],"data,":[760],"such":[761],"as":[762],"EMCDDA,":[767],"help":[769],"regulatory":[770],"law-enforcement":[772],"agencies":[773],"understand":[774,801],"epidemiology":[776],"decide":[781],"whether":[782],"further":[783,796],"control":[784],"and/":[785],"monitoring":[787],"required.":[793],"addition,":[795],"work":[797,858],"needed":[799],"reasons":[803],"misuse,":[805],"enable":[807],"appropriately":[808],"targeted":[809],"harm-reduction":[810],"activities":[811,868],"through":[812],"multi-agency":[813],"responses.":[814],"All":[815],"authors":[816],"Unified":[820],"Competing":[821],"Interest":[822],"form":[823],"http://www.icmje.org/coi_disclosure.pdf":[825],"(available":[826],"request":[828],"corresponding":[831,913],"author)":[832],"declare:":[834],"support":[836],"organization":[839],"submitted":[842,857,876],"work;":[843],"financial":[845],"relationships":[846,866],"organizations":[849],"might":[851],"interest":[854],"previous":[861],"3":[862],"years;":[863],"appear":[871],"influenced":[874],"work.":[877],"S1":[879],"questionnaire":[881],"Please":[882],"note:":[883],"publisher":[885],"responsible":[888],"content":[891],"functionality":[893],"supporting":[896],"information":[897],"supplied":[898],"authors.":[901],"Any":[902],"queries":[903],"(other":[904],"missing":[906],"content)":[907],"should":[908],"directed":[910],"author":[914],"article.":[917]},"counts_by_year":[{"year":2026,"cited_by_count":6},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":8},{"year":2021,"cited_by_count":13},{"year":2020,"cited_by_count":16},{"year":2019,"cited_by_count":9},{"year":2018,"cited_by_count":8},{"year":2017,"cited_by_count":12},{"year":2016,"cited_by_count":8},{"year":2015,"cited_by_count":6},{"year":2014,"cited_by_count":2}],"updated_date":"2026-10-08T09:06:37.294493","created_date":"2025-10-10T00:00:00"}